The Global Beauty Maximizer
DSM continues to lead global peptide research by discovering new cosmetic properties within its peptide innovation platform. SYN-STAR™ – an innovation based on existing patented peptide technology – showed, for the first time, a global anti-ageing and mattifying effect in a study on three different skin tones. The enzyme PLOD3 (procollagen-lysine, -oxoglutarate 5-dioxygenase 3) is known to be important for the stability of intermolecular collagen crosslinks. New in-vitro tests confirmed that SYN-STAR™ stimulates PLOD3, increasing collagen stability, specifically in mature skin, by a factor of more than 4.
Data from other recent research revealed a positive effect of SYN-STAR™ on sebum flow. In an in-vitro assay SYN-STAR™ was shown to inhibit DPP4 (dipeptidyl peptidase-4), a key enzyme involved in sebum flow. A survey of volunteers, 83% of women agreed that they felt more confident and ready for a fabulous day after a 4% treatment with SYN-STAR™.